| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/30/2006 | WO2006034348A2 Enhanced antisense oligonucleotides |
| 03/30/2006 | WO2006034332A2 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 03/30/2006 | WO2006034294A1 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 03/30/2006 | WO2006034061A2 Synthetic nucleic acid molecule and methods of preparation |
| 03/30/2006 | WO2006033999A2 Modified adenovirus containing a fiber replacement protein |
| 03/30/2006 | WO2006033933A2 Antisense antiviral compound and method for treating ssrna viral infection |
| 03/30/2006 | WO2006033854A2 Aptamers to von willebrand factor and their use as thrombotic disease therapeutics |
| 03/30/2006 | WO2006033756A2 Multiple rna polymerase iii promoter expression constructs |
| 03/30/2006 | WO2006033723A2 Production of y-linolenic acid in oleaginous yeast |
| 03/30/2006 | WO2006033708A2 Biotic and abiotic stress tolerance in plants |
| 03/30/2006 | WO2006033689A2 Aav mediated gene delivery to cochlear cells |
| 03/30/2006 | WO2006033672A2 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| 03/30/2006 | WO2006033665A1 Tat-based vaccine compositions and methods of making and using same |
| 03/30/2006 | WO2006033484A1 Nucleic acid microarray and nucleic acid probe designing method, and method of gene detection |
| 03/30/2006 | WO2006033481A1 Soluble toll-like receptor 4 protein |
| 03/30/2006 | WO2006033413A1 Method of quantifying peptide |
| 03/30/2006 | WO2006033409A1 Method of assaying anti-hcv agent with use of cyclophilin |
| 03/30/2006 | WO2006033400A1 Dna detection method and reporter probe |
| 03/30/2006 | WO2006033387A1 Method of detecting gene governing allergic predisposition |
| 03/30/2006 | WO2006033386A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 03/30/2006 | WO2006033384A1 Dna oligomer, gene marker and dna oligomer set for predicting the onset of side effect in radiotherapy and method of predicting the onset of side effect |
| 03/30/2006 | WO2006033368A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 03/30/2006 | WO2006033333A1 Method of producing aldonic acids and aldose dehydrogenase |
| 03/30/2006 | WO2006033020A2 Methods and apparatus for the detection and validation of micrornas |
| 03/30/2006 | WO2006033014A2 Modulation of flowering time and growth cessation in perennial plants |
| 03/30/2006 | WO2006032916A2 A method for increasing seed size |
| 03/30/2006 | WO2006032781A2 Peptide derivatives, compositions and uses in therapeutic treatment of herpesvirus infection |
| 03/30/2006 | WO2006032724A2 Novel laccase enzymes and their uses |
| 03/30/2006 | WO2006032723A1 Novel laccase enzyme and use thereof |
| 03/30/2006 | WO2006032538A1 Methods and means for producing hyaluronan |
| 03/30/2006 | WO2006032528A1 Prohibitin as target for cancer therapy |
| 03/30/2006 | WO2006032279A1 Subtilases |
| 03/30/2006 | WO2006032278A1 Subtilases |
| 03/30/2006 | WO2006032277A1 Subtilases |
| 03/30/2006 | WO2006032102A1 Method of producing fragrance by inactivation or reduction of a functional protein with betaine aldehyde dehydrogenase (badh) activity |
| 03/30/2006 | WO2006017566A9 Modulation of bio-electrical rhythms via a novel engineering approach |
| 03/30/2006 | WO2006012451A3 Compositions and methods of use for mgd-csf in disease treatment |
| 03/30/2006 | WO2006008142A8 Diagnosis and therapy of psoriasis vulgaris |
| 03/30/2006 | WO2005123962A9 Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles |
| 03/30/2006 | WO2005123929A3 Plastid transit peptides |
| 03/30/2006 | WO2005120580A3 Compositions and methods for treatment of fibro-proliferative disorders |
| 03/30/2006 | WO2005120567A3 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof |
| 03/30/2006 | WO2005118643A3 Antibodies to angiogenesis inhibiting domains of cd148 |
| 03/30/2006 | WO2005117994A9 Bmp pathway methods and compositions |
| 03/30/2006 | WO2005115135A9 Mouse model of crohn’s disease and a method to develop specific therapeutics |
| 03/30/2006 | WO2005113779A3 Plant myo-inositol kinase polynucleotides and methods of use |
| 03/30/2006 | WO2005113778A3 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 03/30/2006 | WO2005113764A3 Modulation of wrn-mediated telomere-initiated cell signaling |
| 03/30/2006 | WO2005105838A3 Ion channel |
| 03/30/2006 | WO2005102041A3 Crustacean expression vector |
| 03/30/2006 | WO2005094340A3 Method of reducing insect resistant pests in transgenic crops |
| 03/30/2006 | WO2005084115A3 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof |
| 03/30/2006 | WO2005080579A3 Taxadiene biosynthesis |
| 03/30/2006 | WO2005077333A3 Gel-based delivery of recombinant adeno-associated virus vectors |
| 03/30/2006 | WO2005072112A3 Methods for producing and identifying multispecific antibodies |
| 03/30/2006 | WO2005071093A3 Chimpanzee adenovirus vaccine carriers |
| 03/30/2006 | WO2005068638A3 Promoter |
| 03/30/2006 | WO2005061720A3 High lysine maize compositions and methods for detection thereof |
| 03/30/2006 | WO2005060697A3 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 03/30/2006 | WO2005056795A3 Hif oligonucleotide decoy molecules |
| 03/30/2006 | WO2005047546A3 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders |
| 03/30/2006 | WO2005047321A3 Polynucleotides for inhibition of polypeptide expression and methods of use |
| 03/30/2006 | WO2005037911A3 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions |
| 03/30/2006 | WO2004101744A3 Plants with increased levels of one or more amino acids |
| 03/30/2006 | WO2004096978A3 Production of high mannose proteins in plant culture |
| 03/30/2006 | WO2004065579A3 Modified oligonucleotides for use in gene modulation |
| 03/30/2006 | WO2004053065A3 Disorazole polyketide synthase encoding polynucleotides |
| 03/30/2006 | WO2004048594A3 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
| 03/30/2006 | WO2004043398A3 Modulation of jumonji expression |
| 03/30/2006 | WO2003062369A3 Expansion of renewable stem cell populations |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060070149 Zantedeschia cultivar 7033-01 |
| 03/30/2006 | US20060070148 Zantedeschia cultivar 14087 |
| 03/30/2006 | US20060070147 Zantedeschia cultivar 19208 |
| 03/30/2006 | US20060070146 Wherein the plants of the other corn line comprise a desired trait selected from the group consisting of male sterility, herbicide resistance, insect resistance, and resistance to bacterial, fungal and viral disease |
| 03/30/2006 | US20060070144 comprising transforming plant cells with a polynucleotide linked to a promoter that regulates transcription of a nucleotide sequence that codes for protein which control flowering in plants |
| 03/30/2006 | US20060070143 Wheat variety XW03U |
| 03/30/2006 | US20060070142 Transforming plant an exogenous nucleic acid comprising a floral organ selective regulatory element operatively linked to a nucleotide sequence encoding a cytotoxic gene; selective expression; heritable by progeny; packaging containing expression vector; kits, instructions; genetic engineering |
| 03/30/2006 | US20060070141 Method of repressing flowering in a plant |
| 03/30/2006 | US20060070139 Corn event DAS-59122-7 and methods for detection thereof |
| 03/30/2006 | US20060070138 Seed of cotton cultivar produced by crossing the cultivar 03X179R with itself or another cotton cultivar; insect resistance, herbicide resistance, sterility, enhanced fiber quality |
| 03/30/2006 | US20060070137 Plant-specific genetic elements and transfer cassettes for plant transformation |
| 03/30/2006 | US20060070136 GLYT1 transgenic mouse |
| 03/30/2006 | US20060070133 Comprising a cell specific nuclear targeting signal operably linked to a nucleic acid of interest, wherein the cell specific nuclear targeting signal comprises at least a portion of a surfactant proteinC promoter region; targeting the nuclei of pulmonary epithelial cells;gene therapy |
| 03/30/2006 | US20060069518 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069245 Screening methods for cognitive enhancers |
| 03/30/2006 | US20060069243 Ovary-specific genes and proteins |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069239 Epididymis-specific gene as potential contraceptive target |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069057 Medicaments containing xenogeneic oligo- and/or polyribonucleotides |
| 03/30/2006 | US20060069055 Delivery of polynucleotides |
| 03/30/2006 | US20060069050 Methods and compositions for mediating gene silencing |
| 03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060069023 Animal model for studying hormone signalling and method of modulating the signalling |
| 03/30/2006 | US20060068497 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 03/30/2006 | US20060068496 Differentiation of stem cells |
| 03/30/2006 | US20060068495 Process of cell electrofusion |
| 03/30/2006 | US20060068493 Protein activity screening of clones having DNA from uncultivated microorganisms |